Q2 2023 Telix Pharmaceuticals Ltd Activities Report Call Transcript

Jul 19, 2023 / 10:30PM GMT
Operator

Good day, and thank you for standing by. Welcome to the Telix Second Quarter 2023 Results and Business Update Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Kyahn Williamson, SVP of Investor Relations and Corporate Communications. Kyahn, you may proceed.

Kyahn Williamson - Telix Pharmaceuticals Limited - SVP of Corporate Communications & IR

Well, good morning, and welcome to our investor call today to discuss the Appendix 4C and activity report lodged with the ASX after market close. I'm joined today by Dr. Christian Behrenbruch, our Group CEO; Darren Smith, our Group CFO; and Colin Hayward, our Group Chief Medical Officer. Today, we'll be talking you through the presentation that was lodged on the ASX yesterday afternoon, which is also displayed on the webcast. To those joining by phone, we will give [a word] on each slide change, and then we'll open up to Q&A at the end.

Just moving to the next slide, please, Q2

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot